| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Okt―07 |
Inhaled Ciclesonide for Community-Based COVID-19: A Placebo-Controlled Randomised Trial |
Peter Wark, Ian C. Marschner, Owen Hutchings, Gemma Blunt, Greg J. Fox, Meg Jardine, Thomas Snelling, Arlen Wilcox, Emily Amico, Karen Allison, Kate Wilson, John Simes, Guy B. Marks |
| 2 |
[GO] |
2024―Sep―04 |
A 5-year perspective on coronavirus diseases 2019 (COVID-19) |
David S. C. Hui, Alimuddin Zumla |
| 3 |
[GO] |
2024―Jan―31 |
Increased exacerbations of bronchiectasis following recovery from mild COVID-19 in patients with non-cystic fibrosis bronchiectasis |
Wang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, Mary Sau Man Ip, David Chi Leung Lam |
| 4 |
[GO] |
2023―Sep―21 |
Continuous positive airway pressure or high-flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure unrelated to COVID-19: Another brick in the wall? |
Rémi Coudroy |
| 5 |
[GO] |
2023―Sep―16 |
Treatable traits for long COVID |
Hayley Lewthwaite, Anthony Byrne, Bruce Brew, Peter G. Gibson |
| 6 |
[GO] |
2023―Sep―08 |
Long-term effects of extreme smoke exposure on COVID-19: A cohort study |
Tyler J. Lane, Matthew Carroll, Brigitte M. Borg, Tracy A. McCaffrey, Catherine L. Smith, Caroline X. Gao, David Brown, David Poland, Shantelle Allgood, Jillian Ikin, Michael J. Abramson |
| 7 |
[GO] |
2023―Aug―22 |
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia |
Giacomo Sgalla, Paolo Maria Leone, Gina Gualano, Jacopo Simonetti, Alessia Comes, Diana Verdirosi, Francesco Di Gennaro, Anna Rita Larici, Stefania Ianniello, Giuseppe Cicchetti, Nicoletta Fusco, Marcello Pani, Fabrizio Palmieri, Luca Richeldi |
| 8 |
[GO] |
2023―Jul―27 |
Letter from the United States: An update on the New York experience with COVID-19 |
Edward J. Schenck, Meredith L. Turetz, Michael S. Niederman |
| 9 |
[GO] |
2023―Jul―21 |
A snorkel mask with a 3D-printed adaptor to HEPA filter was used in a COVID-19 emergency ward to provide safe respiratory support |
Camila Vitelli Molinari, Vivian Bertoni Xavier, Ronaldo Fernandes Rosa, Maria Augusta Junqueira Alves, Luiz Antônio Rivetti, Vera Lúcia dos Santos Alves |
| 10 |
[GO] |
2023―Mai―19 |
Let us start thinking about what to do in the event of a global influenza pandemic |
Richard Beasley |
| 11 |
[GO] |
2023―Mai―08 |
Covid-19 pandemic and asthma: What did we learn? |
Chloe I. Bloom |
| 12 |
[GO] |
2022―Nov―02 |
Are we coming out from the
COVID
-19 pandemic? |
Chi Chiu Leung, Andrew C. K. Lee |
| 13 |
[GO] |
2022―Okt―17 |
Two years of the pandemic suppressed deaths from
non-COVID
-19 respiratory infections: A nationwide surveillance in Japan |
Nobuyuki Horita, Takeshi Fukumoto |
| 14 |
[GO] |
2022―Sep―22 |
The ill winds of
COVID
-19: How the pandemic improved respiratory health for some |
Robert J. Hancox, Catherina L. Chang |
| 15 |
[GO] |
2022―Aug―11 |
Respiratory admissions before and during the COVID-19 pandemic with mediation analysis of air pollutants, mask-wearing and influenza rates |
Fanny Wai San Ko, Louis Ho Shing Lau, So Shan Ng, Terry Cheuk Fung Yip, Grace Lai Hung Wong, Ka Pang Chan, Tat On Chan, David Shu Cheong Hui |
| 16 |
[GO] |
2022―Aug―10 |
Pulmonary function testing during
SARS-CoV
-2: An
ANZSRS
/
TSANZ
position statement |
Brigitte M. Borg, Christian Osadnik, Keith Adam, David G. Chapman, Catherine E. Farrow, Vanda Glavas, Kerry Hancock, Celia J. Lanteri, Ewan G. Morris, Nicholas Romeo, Elena K. Schneider-Futschik, Hiran Selvadurai |
| 17 |
[GO] |
2022―Mai―05 |
Innovations during the
Covid
-19 pandemic to maintain delivery of care for vocal cord dysfunction (
VCD
) in a multidisciplinary team (
MDT
) clinic |
Joo Koh, Malcolm Baxter, Debra Phyland, Laurence Ruane, Adriana Avram, Elizabeth Leahy, Kenneth Lau, Martin MacDonald, Paul Leong, Philip Bardin |
| 18 |
[GO] |
2022―Apr―27 |
Reply: Hearing the voices of Australian frontline healthcare workers during the COVID-19 pandemic |
Natasha Smallwood, Jaimie-Lee Maple, Karen Willis |
| 19 |
[GO] |
2022―Apr―13 |
The ongoing impact of
COVID
-19 pandemic restrictions on the cardio-respiratory health of New Zealanders |
Sarah M. Fairweather, Catherina L. Chang, Robert J. Hancox |
| 20 |
[GO] |
2022―Mrz―25 |
Lessons learned from staging the Olympics during a pandemic |
Yoichi Nakanishi |
| 21 |
[GO] |
2022―Jan―20 |
COVID
-19 infection and the broader impacts of the pandemic on healthcare workers |
Natasha Smallwood, Warren Harrex, Megan Rees, Karen Willis, Catherine M. Bennett |
| 22 |
[GO] |
2022―Jan―05 |
Changes to clinical education during the
COVID
-19 pandemic: Challenges and opportunities |
Mark Lavercombe |
| 23 |
[GO] |
2021―Dez―06 |
COVID-19
and critical care capacity: Can we mitigate demand? |
Matthew Byrne, Timothy E. Scott, Jonathan Sinclair, Nachiappan Chockalingam |
| 24 |
[GO] |
2021―Nov―22 |
Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic |
Nobuyuki Horita, Hideaki Kato, Keisuke Watanabe, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko |
| 25 |
[GO] |
2021―Nov―20 |
P5-72: Lipid involvements on inflammatory changes and clinical outcomes in patients with COVID-19 |
|
| 26 |
[GO] |
2021―Nov―20 |
P5-89: Effectiveness of a questionnaire to screen COVID-19 |
|
| 27 |
[GO] |
2021―Nov―20 |
P5-90: Association of persistent and delayed symptoms with pneumonia in COVID-19 |
|
| 28 |
[GO] |
2021―Nov―20 |
P5-91: Clinical characteristics and mortality risk in patients with severe COVID-19 |
|
| 29 |
[GO] |
2021―Nov―20 |
P5-23: Neurological complications of patients with COVID-19 |
|
| 30 |
[GO] |
2021―Nov―20 |
P5-53: Early initiation of steroid therapy is a risk factor of treatment failure in patients with COVID-19 |
|
| 31 |
[GO] |
2021―Nov―20 |
P5-58: Efficacy of concurrent administration of tocilizumab with corticosteroids for patients with COVID-19 |
|
| 32 |
[GO] |
2021―Nov―20 |
P5-47: Safety and efficacy of remdesivir, baricitinib and high-dose steroid combination therapy in patients hospitalized with COVID-19 |
|
| 33 |
[GO] |
2021―Nov―20 |
P1-26: Cytokines secreted by PC9-MET and PC9 cells may worsen COVID-19 |
|
| 34 |
[GO] |
2021―Nov―20 |
P5-34: Long-haul COVID-19 among University of Santo Tomas hospital-health care workers following hospitalization for COVID-19 pneumonia |
|
| 35 |
[GO] |
2021―Nov―20 |
P6-56: One case of a patient on maintenance dialysis who concurrently suffered from both COVID-19 and a relapse of pulmonary tuberculosis |
|
| 36 |
[GO] |
2021―Nov―20 |
P6-58: Pneumothorax as a clinical manifestation of lung tuberculosis with co-infection COVID-19 and bacterial pneumonia |
|
| 37 |
[GO] |
2021―Nov―20 |
P1-86: Prone positioning treatment for COVID-19 ARDS patients with pneumomediastinum and subcutaneous emphysema during treatment of mechanical ventilation.: A two cases report |
|
| 38 |
[GO] |
2021―Nov―20 |
P11-6: Indices of endogenous intoxication in patients with COVID-19 associated pneumonia |
|
| 39 |
[GO] |
2021―Nov―20 |
P5-81: Correlation of serum ferritin level with disease severity of COVID-19 at Arifin Achmad General Hospital Riau Province |
|
| 40 |
[GO] |
2021―Nov―20 |
P5-82: The correlation of cycle threshold value with severity of COVID-19 at the isolation of new emerging and re-emerging infectious diseases room Arifin Achmad General Hospital Riau Province Indonesia |
|
| 41 |
[GO] |
2021―Nov―20 |
P1-78: Descriptive analysis of patients attending an outpatient post COVID-19 clinic in a tertiary care hospital in Sri Lanka |
|
| 42 |
[GO] |
2021―Nov―20 |
P5-8: Risk factors for mortality of COVID-19 confirmed cases admitted at lung center of the Philippines |
|
| 43 |
[GO] |
2021―Nov―20 |
P5-113: Baseline characteristics, clinical course and outcomes of COVID-19 confirmed healthcare workers in the University of Santo Tomas Hospital |
|
| 44 |
[GO] |
2021―Nov―20 |
P11-5: Clinical outcomes of hypoxemic, COVID-19 confirmed patients on high-flow nasal cannula (HFNC) therapy in a tertiary government hospital in Metro Manila, Philippines: A retrospective study |
|
| 45 |
[GO] |
2021―Nov―20 |
O19-3: The outcomes of evolving treatment regimens among COVID-19 Confirmed severe and critical cases admitted at the lung center of the Philippines |
|
| 46 |
[GO] |
2021―Nov―20 |
P5-98: Vitamin D deficiency as a marker of severe COVID-19 course |
|
| 47 |
[GO] |
2021―Nov―20 |
P5-104: Reinfection of COVID-19 critical condition in miliary tuberculosis case with multiple comorbidities |
|
| 48 |
[GO] |
2021―Nov―20 |
P6-44: Case report of a newly diagnosed bacteriologically confirmed pulmonary tuberculosis in a patient with COVID-19 critical infection |
|
| 49 |
[GO] |
2021―Nov―20 |
P5-54: Guillain-Barre syndrome-acute motor axonal neuropathy as neurologic sequela in a COVID-19 critically-ill patient: A case report |
|
| 50 |
[GO] |
2021―Nov―20 |
P5-77: Prognostic factors associated with death and progressiveness of COVID-19 disease at Sanglah Hospital, Denpasar |
|
| 51 |
[GO] |
2021―Nov―20 |
P5-30: Risk factors for hospitalization in patients with mild SARS-CoV-2 infection (COVID-19) during residential or home care |
|
| 52 |
[GO] |
2021―Nov―20 |
P5-42: Assessment of outcome and risk categorization of COVID-19 exposed healthcare workers using a risk assessment tool in a Tertiary Care Hospital, Sri Lanka |
|
| 53 |
[GO] |
2021―Nov―20 |
P5-88: Study of C reactive protein (HS-CRP) in post COVID-19 geriatric patients |
|
| 54 |
[GO] |
2021―Nov―20 |
P5-101: A case report of COVID-19 in an adult filipino with HIV-associated histoplasmosis |
|
| 55 |
[GO] |
2021―Nov―20 |
P13-2: The effect of vitamin D on the course of COVID-19 in children |
|
| 56 |
[GO] |
2021―Nov―20 |
P5-6: A convenient risk prediction score for COVID-19 in determining whether hospitalization should be recommended: Kanagawa admission priority assessment score (KAPAS) |
|
| 57 |
[GO] |
2021―Nov―20 |
P5-132: Rehabilitation interventions and tasks for patients with COVID-19 in our hospital |
|
| 58 |
[GO] |
2021―Nov―20 |
P5-60: Clinical and radiological features of COVID-19 in pregnant women: A case-control study |
|
| 59 |
[GO] |
2021―Nov―20 |
P1-74: COVID-19 in renal transplant recipients in a resource poor setting: A case series |
|
| 60 |
[GO] |
2021―Nov―20 |
P1-95: It runs in the family: case series of severe and critical COVID-19 in three family members |
|
| 61 |
[GO] |
2021―Nov―20 |
P5-74: Serial changes in clinical characteristics of COVID-19 infected patients |
|
| 62 |
[GO] |
2021―Nov―20 |
P16-97: Secondary organizing pneumonia following COVID-19 infection |
|
| 63 |
[GO] |
2021―Nov―20 |
P5-118: Clinical outcomes of diffuse alveolar damage and organising pneumonia in severe COVID-19 infection |
|
| 64 |
[GO] |
2021―Nov―20 |
O5-2: Factors affecting compliance to COVID-19 infection prevention and control measures and its effects on the risk of COVID-19 infection among physicians in a tertiary government hospital |
|
| 65 |
[GO] |
2021―Nov―20 |
P5-138: Correlation between brixia score and RTPCR-SARS-CoV-2 result of pediatric patients with suspected or confirmed COVID-19 infection seen at Chong Hua Hospital, Cebu City from March 2020 to February 2021 |
|
| 66 |
[GO] |
2021―Nov―20 |
P1-79: Diaphragm dysfunction developed after COVID-19 infection without pneumonia |
|
| 67 |
[GO] |
2021―Nov―20 |
P1-24: Correlation of chest CT findings and severity of coronavirus disease (COVID-19) infections in patients admitted at Chinese General Hospital and Medical Center |
|
| 68 |
[GO] |
2021―Nov―20 |
P5-13: COVID-19 mobile test unit (COMBAT): A novel pharyngeal sampling platform for COVID-19 testing in Malaysia |
|
| 69 |
[GO] |
2021―Nov―20 |
P1-15: Chest X-ray improvement in COVID-19 moderate symptoms with remdesvir and favipiravir: A comparative study |
|
| 70 |
[GO] |
2021―Nov―20 |
P5-37: Community-acquired respiratory virus cases mimic COVID-19 on lung computed tomography |
|
| 71 |
[GO] |
2021―Nov―20 |
P6-5: Impact of COVID-19 on tuberculosis in Japan; A national database analysis |
|
| 72 |
[GO] |
2021―Nov―20 |
P16-60: Post COVID-19 organizing pneumonia treated with mycophenolate mofetil |
|
| 73 |
[GO] |
2021―Nov―20 |
P1-51: Status of palliative care in respiratory disease before and after COVID-19 outbreak |
|
| 74 |
[GO] |
2021―Nov―20 |
P3-6: A clinical analysis of PAP (pulmonary alveolar proteinosis) s diagnosed with difficulty in the COVID-19 pandemic |
|
| 75 |
[GO] |
2021―Nov―20 |
P12-8: New style for bronchoscopy to prevent infection under COVID-19 pandemic |
|
| 76 |
[GO] |
2021―Nov―20 |
P8-180: Growth inhibitory effects of chemotherapeutics drugs in EGFR-mutated PC9 cells during the COVID-19 pandemic |
|
| 77 |
[GO] |
2021―Nov―20 |
P1-8: Impact on inhalation adherence of asthma and COPD patients during the COVID-19 pandemic |
|
| 78 |
[GO] |
2021―Nov―20 |
P16-95: High incidence of MPO-ANCA positive interstitial pneumonia during the COVID-19 pandemic |
|
| 79 |
[GO] |
2021―Nov―20 |
O17-1: Asthma status during COVID-19 pandemic |
|
| 80 |
[GO] |
2021―Nov―20 |
P4-10: Burnout among healthcare workers during COVID-19 pandemic in Aceh, Indonesia |
|
| 81 |
[GO] |
2021―Nov―20 |
P5-92: Respiratory viruses during COVID-19 pandemic in Okinawa, Japan |
|
| 82 |
[GO] |
2021―Nov―20 |
P5-33: Impacts of the COVID-19 pandemic on hospitalizations for pneumonia in Brazil |
|
| 83 |
[GO] |
2021―Nov―20 |
P4-25: The dynamics of the quality of life of healthy people amid the COVID-19 pandemic when soy and pumpkin products are included in the diet |
|
| 84 |
[GO] |
2021―Nov―20 |
P5-109: A fatal case of multiple mycotic pulmonary artery aneurysms due to
Aspergillus terreus
in a post COVID-19 patient |
|
| 85 |
[GO] |
2021―Nov―20 |
P1-2: Correlations in physical symptoms, blood biochemical findings, and chest ct images in an early phase of COVID-19 patient |
|
| 86 |
[GO] |
2021―Nov―20 |
P11-11: Bilateral iliopsoas hematomas in a severe COVID-19 patient treated with unfractionated heparin: A case report and review of literature |
|
| 87 |
[GO] |
2021―Nov―20 |
P12-12: Bronchoscopy with n-acetylcysteine lavage in a COVID-19 patient with massive grade IV inhalation injury |
|
| 88 |
[GO] |
2021―Nov―20 |
P5-46: Myocardial injury association with severity of disease in hospitalized COVID-19 patients |
|
| 89 |
[GO] |
2021―Nov―20 |
P5-108: The association between awake prone positioning and mortality in COVID-19 patients |
|
| 90 |
[GO] |
2021―Nov―20 |
P1-13: Effect of bromhexine among COVID-19 patients - A meta-analysis |
|
| 91 |
[GO] |
2021―Nov―20 |
P5-20: The prevalence of comorbid respiratory disease among COVID-19 patients, and mortality during the first wave in Japan: A nationwide survey by the Japanese Respiratory Society |
|
| 92 |
[GO] |
2021―Nov―20 |
P5-127: Clinical characteristics of SARS-CoV-2 infected (COVID-19) patients and mutant viral strains in rural area of Japan |
|
| 93 |
[GO] |
2021―Nov―20 |
P5-27: Evaluation of serum interferon lambda 3 in hospitalized COVID-19 patients as a biomarker to predict the severity |
|
| 94 |
[GO] |
2021―Nov―20 |
P5-83: The correlation between cycle threshold polymerase chain reaction COVID-19 with the extent of chest X-ray abnormalities and D-dimer in COVID-19 patients at Arifin Achmad General Hospital Riau Province |
|
| 95 |
[GO] |
2021―Nov―20 |
P5-135: D-dimer as a predictor severity and mortality in hospitalized COVID-19 patients at Saiful Anwar General Hospital Malang |
|
| 96 |
[GO] |
2021―Nov―20 |
P1-9: Predictive factor of high-flow nasal oxygen failure in COVID-19 patients at tertiary hospital in Jakarta |
|
| 97 |
[GO] |
2021―Nov―20 |
P5-136: The correlation between leucocyte, lymphocyte, thrombocyte, and sofa score on the severity of COVID-19 patients hospitalized in the PINERE Ward of Saiful Anwar Hospital |
|
| 98 |
[GO] |
2021―Nov―20 |
O6-4: Treatment outcomes of COVID-19 patients in Hong Kong's first designated infection control centre and the impact of emergent SARS-CoV-2 mutant strains from imported cases |
|
| 99 |
[GO] |
2021―Nov―20 |
P1-36: Multicenter study elucidating factors associated with sequelae of discharged COVID-19 patients in Japan |
|
| 100 |
[GO] |
2021―Nov―20 |
P5-68: The use of an institutionalized respiratory protocol as a decision-making tool improved outcomes among severe and critically-ill COVID-19 patients in Perpetual Succour Hospital |
|
| 101 |
[GO] |
2021―Nov―20 |
O8-5: Prevalence of acute myocardial injury among COVID-19 patients in Persahabatan Hospital, Jakarta |
|
| 102 |
[GO] |
2021―Nov―20 |
P5-145: COVID-19: Performance of oseltamivir and isoprinosine in neutrophil-to-lymphocyte ratio improvement from confirmed COVID-19 patients in Saiful Anwar General Hospital, Malang |
|
| 103 |
[GO] |
2021―Nov―20 |
P5-36: Association of C-reactive protein (CRP), serum ferritin, and patient outcome in COVID-19 patients in tertiary referral hospital |
|
| 104 |
[GO] |
2021―Nov―20 |
P5-105: Relationship of total thrombocyte, lymphocyte account and PLR (platelet lymphocyte ratio) to severity degree of COVID-19 patients in ward |
|
| 105 |
[GO] |
2021―Nov―20 |
P11-14: Blood gas analysis and alveolar-arterial gradient as predictor of mortality confirmed COVID-19 patients outcome in Tertiary Referral Hospital |
|
| 106 |
[GO] |
2021―Nov―20 |
P5-112: The relationship of chest X-ray in COVID-19 patients towards disease severity at Arifin Achmad Regional General Hospital, Riau Province |
|
| 107 |
[GO] |
2021―Nov―20 |
P5-76: Prolonged viral clearance in COVID-19 patients treated with tocilizumab |
|
| 108 |
[GO] |
2021―Nov―20 |
P5-142: A case series on corticosteroid use in COVID-19 patients who suffered from chronic lung disease |
|
| 109 |
[GO] |
2021―Nov―20 |
P5-150: COVID-19 patients with a late diagnosis of HIV |
|
| 110 |
[GO] |
2021―Nov―20 |
P5-70: Effectiveness of favipiravir in COVID-19 patients with multiple (≥2) or less (<2) comorbidities: A real word experience from India |
|
| 111 |
[GO] |
2021―Nov―20 |
P5-106: Japanese, multicenter, phase II trial of combination therapy with favipiravir and methylprednisolone for COVID-19 patients with non-critical respiratory failure: the J-critical trial |
|
| 112 |
[GO] |
2021―Nov―20 |
P5-79: Clinical comparison of the first wave and the later waves in COVID-19 patients with pneumonia |
|
| 113 |
[GO] |
2021―Nov―20 |
P5-64: Therapeutic effectiveness & safety of favipiravir in COVID-19 patients with risk factors for mortality: Clinical practice experience from India |
|
| 114 |
[GO] |
2021―Nov―20 |
P5-19: Spontaneous pneumothorax in Indonesian COVID-19 patients: A retrospective case series |
|
| 115 |
[GO] |
2021―Nov―20 |
P5-71: Rapidly progressive honeycombing in a spontaneously breathing patient with COVID-19 pneumonia |
|
| 116 |
[GO] |
2021―Nov―20 |
P5-62: Evaluation of lung cell populations in severe COVID-19 pneumonia |
|
| 117 |
[GO] |
2021―Nov―20 |
P5-87: Time course of oxygen demand in patients with COVID-19 pneumonia |
|
| 118 |
[GO] |
2021―Nov―20 |
P5-85: Staged treatment of middle lobe lung gangrene using the vacuum-assisted closure therapy in a patient with severe COVID-19 pneumonia |
|
| 119 |
[GO] |
2021―Nov―20 |
P5-152: Familial ciclesonide-responsive cases of COVID-19 pneumonia |
|
| 120 |
[GO] |
2021―Nov―20 |
P5-144: Infected pneumatoceles complicating the course of COVID-19 pneumonia |
|
| 121 |
[GO] |
2021―Nov―20 |
P1-77: Long-COVID syndrome associated with COVID-19 pneumonia |
|
| 122 |
[GO] |
2021―Nov―20 |
P5-57: Comparison of chest HRCT findings between COVID-19 pneumonia and anti-MDA5 antibody-positive interstitial pneumonia by computer-based quantitative CT image analysis |
|
| 123 |
[GO] |
2021―Nov―20 |
P5-14: An age-matched comparison between COVID-19 pneumonia and pneumococcal pneumonia cases |
|
| 124 |
[GO] |
2021―Nov―20 |
P5-15: A case of recurred exacerbations and remissions of COVID-19 pneumonia in a patient with b-cell lymphoma undergoing chemotherapy |
|
| 125 |
[GO] |
2021―Nov―20 |
P5-43: A case of hyperpyrexia of hypothalamic origin associated with severe COVID-19 pneumonia in pregnancy |
|
| 126 |
[GO] |
2021―Nov―20 |
P5-26: Validity of PIRO-score as an assessment tool for mortality risk of COVID-19 pneumonia in World Citi Medical Center. A retrospective observational cohort study |
|
| 127 |
[GO] |
2021―Nov―20 |
P11-13: Diffuse pulmonary hemorrhage, a catastrophic outcome of a 57-year-old venezuelan, with COVID-19 pneumonia, who developed multiple thrombosis and aman-variant GBS |
|
| 128 |
[GO] |
2021―Nov―20 |
P1-83: A case report of primi 30 weeks of pregnancy with COVID-19 pneumonia with dengue fever |
|
| 129 |
[GO] |
2021―Nov―20 |
P5-97: High-dose methylprednisolone in combination with tocilizumab in hospitalized patients with critical COVID-19 pneumonia: A case series |
|
| 130 |
[GO] |
2021―Nov―20 |
P5-67: Predictors of mortality in severe COVID-19 pneumonia: An interim analysis from a single Tertiary Care Centre in Central Sri Lanka |
|
| 131 |
[GO] |
2021―Nov―20 |
P5-80: A case report of pneumothorax associated with COVID-19 pneumoniae |
|
| 132 |
[GO] |
2021―Nov―20 |
P5-143: Post-corona virus disease 2019 (COVID-19) pneumothorax |
|
| 133 |
[GO] |
2021―Nov―20 |
P15-16: Modified dose thrombolysis in a COVID-19 related massive acute pulmonary embolism: A case report |
|
| 134 |
[GO] |
2021―Nov―20 |
P5-125: Abrupt cessation of systemic corticosteroid in coronavirus disease 19 (COVID-19) related secondary organizing pneumonia resulted in a rebound |
|
| 135 |
[GO] |
2021―Nov―20 |
O10-1: Community-led tuberculosis and COVID-19 risk communication in the Vietnamese migrant population in Japan |
|
| 136 |
[GO] |
2021―Nov―20 |
P5-28: Correlation of serum interleukin-6 level and COVID-19 severity on hospital admission and survival |
|
| 137 |
[GO] |
2021―Nov―20 |
P14-9: Lung function analysis of COVID-19 survivors in dr. Zainoel Abidin Hospital Banda Aceh, Indonesia |
|
| 138 |
[GO] |
2021―Nov―20 |
P5-122: A case of secondary organizing pneumonia caused by relapse of inflammation after COVID-19 treatment with systemic corticosteroid and tocilizumab |
|
| 139 |
[GO] |
2021―Nov―20 |
O8-4: Determination of antibody titers of filipino healthcare workers after COVID-19 vaccination (Sinovac and Astrazenica) - A preliminary report |
|
| 140 |
[GO] |
2021―Nov―20 |
O7-1: Structural differentiation of the spike glycoprotein from SARS-CoV-2 COVID-19 variants of concern compared to other human-infecting coronaviruses: A computational study with clinical implications |
|
| 141 |
[GO] |
2021―Nov―20 |
P11-2: Clinical profiles and respiratory system mechanics of mechanically ventilated patients with COVID-19 versus non-COVID-19-associated ARDS |
|
| 142 |
[GO] |
2021―Nov―20 |
P5-31: High prevalence of silent hypoxia among patients with COVID-19 warrants screening for oxyhemoglobin desaturation among patients with fever, cough or dyspnea |
|
| 143 |
[GO] |
2021―Nov―20 |
P5-40: An autopsy case of COVID-19 with disseminated mucormycosis |
|
| 144 |
[GO] |
2021―Nov―20 |
P7-61: Management & caring for patients of COPD with COVID-19: A current perspective |
|
| 145 |
[GO] |
2021―Nov―20 |
P5-121: Inhaled beclomethasone in the treatment of early COVID-19: A placebo-controlled, randomized trial |
|
| 146 |
[GO] |
2021―Nov―20 |
O8-3: The effectiveness of the combined use of remdesivir and regdanvimab (CT-P59) in patients with severe COVID-19: A single center retrospective study |
|
| 147 |
[GO] |
2021―Nov―20 |
P11-7: Issues related to ECMO management in critically ill patients with COVID-19: A systematic review and meta-analysis |
|
| 148 |
[GO] |
2021―Nov―20 |
P5-111: SARS-CoV-2 PCR and antigen positivity continued for 3 months after treatment for severe COVID-19: Case report |
|
| 149 |
[GO] |
2021―Nov―20 |
P5-51: Organizing pneumonia post COVID-19: Outcomes of treatment with corticosteroids in the outpatient setting |
|
| 150 |
[GO] |
2021―Nov―20 |
P5-93: Therapeutic effectiveness and tolerability of favipiravir in mild COVID-19: Real world experience from India |
|
| 151 |
[GO] |
2021―Nov―20 |
P5-32: Investigation of exacerbation factors in patients with coronavirus disease 2019 |
|
| 152 |
[GO] |
2021―Nov―20 |
P6-50: Primary multidrug-resistant tuberculosis in coronavirus disease 2019 |
|
| 153 |
[GO] |
2021―Nov―20 |
P5-94: The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019 |
|
| 154 |
[GO] |
2021―Nov―20 |
P5-56: Predictive model for the development of critical coronavirus disease 2019 in Japan |
|
| 155 |
[GO] |
2021―Nov―20 |
P8-37: Delayed visit and treatment of lung cancer during the coronavirus disease 2019 pandemic in Japan |
|
| 156 |
[GO] |
2021―Nov―20 |
P1-34: Passive microwave radiometry as an early screening diagnostic of pneumonia due to coronavirus infection 2019 lung complications in Kyrgyzstan |
|
| 157 |
[GO] |
2021―Nov―20 |
P5-55: What kind of disease has developed in a teenager against the background of a new coronavirus infection? Is it Kawasaki's or Reye's syndrome? |
|
| 158 |
[GO] |
2021―Nov―20 |
P1-94: The challenges of patients that with home using long term oxygen therapy under coronavirus pandemic |
|
| 159 |
[GO] |
2021―Nov―20 |
P5-149: Investigation of antibody level by the presence or absence of side effects after the new coronavirus vaccine |
|
| 160 |
[GO] |
2021―Nov―20 |
P13-1: Chest X-ray findings of coronavirus-19 disease in patients age 0 to 18 years old admitted at Chong Hua Hospital from March 2020 to February 2021 |
|
| 161 |
[GO] |
2021―Nov―20 |
O6-3: Bioinformatics analysis of high-throughput sequencing to identify key genes and signaling pathways in vero E6 cells infected by SARS-CoV-2 |
|
| 162 |
[GO] |
2021―Nov―20 |
P6-12: The cruel dual; SARS-CoV-2 and tuberculosis co-infection, the Sri Lankan experience |
|
| 163 |
[GO] |
2021―Nov―20 |
P5-24: Severity and clinical outcome of SARS-CoV-2 infected patients following COVID vaccination - An observational study in Bangladesh |
|
| 164 |
[GO] |
2021―Nov―20 |
P5-123: The clinical features and outcomes of discharged SARS-CoV-2 patients: A prospective cohort study |
|
| 165 |
[GO] |
2021―Nov―20 |
P2-40: Expression of the SARS-CoV-2 receptor ACE2 and proinflammatory cytokines induced by the periodontopathic bacterium
Fusobacterium nucleatum
in human respiratory epithelial cells |
|
| 166 |
[GO] |
2021―Nov―20 |
P5-41: Rapid and simultaneous identification of multiple mutations by the Novaplex
TM
SARS-CoV-2 variants assay kits |
|
| 167 |
[GO] |
2021―Nov―20 |
P10-24: Successful extubation in a phenobarbital overdose attempted suicide in a non-ideal set-up at the time of COVID 19 pandemic |
|
| 168 |
[GO] |
2021―Nov―20 |
P5-11: Vaccine-induced immune thrombotic thrombocytopenia (VITT) after
ChAdOx1 nCoV-19
vaccination |
|
| 169 |
[GO] |
2021―Nov―10 |
Clinical differentiation of severe acute respiratory syndrome coronavirus 2 pneumonia using the Japanese guidelines |
Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Shosaku Nomura |
| 170 |
[GO] |
2021―Sep―01 |
Mental health among healthcare workers during the
COVID
-19 pandemic |
Natasha Smallwood, Karen Willis |
| 171 |
[GO] |
2021―Aug―30 |
Air pollution and the pandemic: Long-term
PM
2.5
exposure and disease severity in
COVID
-19 patients |
Angelico Mendy, Xiao Wu, Jason L. Keller, Cecily S. Fassler, Senu Apewokin, Tesfaye B. Mersha, Changchun Xie, Susan M. Pinney |
| 172 |
[GO] |
2021―Aug―24 |
Decline in respiratory and cardiac admissions during the
COVID
-19 pandemic: What is the role of common respiratory virus infections? |
Chloe I. Bloom, Sebastian L. Johnston |
| 173 |
[GO] |
2021―Aug―13 |
Risk of severe acute respiratory syndrome coronavirus 2 (
SARS-CoV
-2) transmission during bronchoscopy in the intensive care unit |
Biplab K. Saha, Praveen Chenna |
| 174 |
[GO] |
2021―Aug―08 |
Impact of
COVID
-19 pandemic restrictions on the cardio-respiratory health of New Zealanders |
Sarah M. Fairweather, Catherina L. Chang, Christopher J Mansell, Eskandarain Shafuddin, Robert J. Hancox |
| 175 |
[GO] |
2021―Jun―28 |
The 1918 influenza and
COVID
-19 pandemics: The effect of age on outcomes |
Paul T. King, Sarah L. Londrigan |
| 176 |
[GO] |
2021―Mai―27 |
Pathophysiology of infection with SARS-CoV
-2-
What is known and what remains
a
mystery |
Siddharth Sridhar, John Nicholls |
| 177 |
[GO] |
2021―Mrz―08 |
Provision of essential bronchoscopy during
COVID
-19 pandemic |
Waheed Shah, Orla O'Carroll, Michael P. Keane, Cormac McCarthy |
| 178 |
[GO] |
2021―Mrz―02 |
Letter from Canada: A pandemic that has humbled us? |
Stephan F. van Eeden |
| 179 |
[GO] |
2020―Dez―16 |
Delayed access to lung cancer screening and treatment during the
COVID
-19 pandemic: Are we headed for a lung cancer pandemic? |
Tracy L. Leong |
| 180 |
[GO] |
2020―Okt―14 |
Attenuating COVID-19 infection and inflammation: Lessons from asthma |
Philip G. Bardin, Sebastian L. Johnston |
| 181 |
[GO] |
2020―Sep―22 |
Respiratory management of adult patients with acute respiratory distress syndrome due to COVID-19 |
Priyanka Makkar, Stephen M Pastores |
| 182 |
[GO] |
2020―Sep―21 |
Pulmonary rehabilitation in
COVID
-19 pandemic era: The need for a revised approach |
Ajay Prashad Gautam, Ross Arena, Snehil Dixit, Audrey Borghi-Silva |
| 183 |
[GO] |
2020―Aug―18 |
Letter from Singapore: The clinical and research response to COVID-19 |
Sanjay H. Chotirmall, Lin-Fa Wang, John A. Abisheganaden |
| 184 |
[GO] |
2020―Jul―07 |
Universal public mask wear during
COVID
-19 pandemic: Rationale, design and acceptability |
Christopher Liu, Rawya Diab, Hasan Naveed, Victor Leung |
| 185 |
[GO] |
2020―Jun―17 |
Targeting the interleukin-17 pathway to prevent acute respiratory distress syndrome associated with
SARS-CoV
-2 infection |
Tomas Raul Wiche Salinas, Boyang Zheng, Jean-Pierre Routy, Petronela Ancuta |
| 186 |
[GO] |
2020―Mai―21 |
The role of
SARS-CoV
-2 antibodies in
COVID
-19: Healing in most, harm at times |
Martyn A. French, Yuben Moodley |
| 187 |
[GO] |
2020―Mai―14 |
Safe performance of diagnostic bronchoscopy/
EBUS
during the
SARS-CoV
-2 pandemic |
Daniel P. Steinfort, Felix J.F. Herth, Louis B. Irving, Phan T. Nguyen |
| 188 |
[GO] |
2020―Apr―11 |
Summarizing societal guidelines regarding bronchoscopy during the COVID-19 pandemic |
Robert J. Lentz, Henri Colt |
